Raul Calfat

Raul has been Chairman of the Board of Directors of Aché Laboratórios Farmacêuticos since September 2018.

In May 2015, he became an Independent Member of the Board of Directors of Duratex S.A. (current Dexco S.A.) and his term of office will end in April 2023. He will not be reelected. He has been an Independent Member of the Board of Directors of Embraer since April 2017 and he is currently its Vice Chairman. He has been an Independent Member of the Advisory Board of China Three Gorges Brasil since January 2021.He has been an Independent Member of the Board of Directors of Fleury S.A. since May 2021 and his term of office will end in April 2023. He will not be reelected.

He is also a Senior Advisor at the following companies: RGE Pte Ltd in Singapore and Bracell SP Celulose Ltda. since March 2020 and Macquarie Serviços Agrícolas Participações Ltda. since January 2020. He was a Member of the Board of Hospital Sírio Libanês from 2015 to 2020.

From January 2014 to April 2019, he was the Chairman of the Board of Directors of Votorantim S.A., from December 2009 to December 2018, he was a Member of the Board of Directors of Fibria Celulose S.A. and from January 2010 to December 2013, he served as CEO of Votorantim Industrial and led the cement, ore and mining, pulp, steel and iron, orange juice and energy departments of the Group. Between 2004 and 2010, he was the General Director of the holding company.

Before that, between 1995 and 2003, he was the CEO of Votorantim Celulose e Papel (current Fibria) and CEO of Papel Simão from 1987 to 1992, the company where he started his career as trainee in 1973. He was the Chairman of the São Paulo Pulp and Paper Association from 1993 to 1995 and was the Vice President of the Brazilian Pulp and Paper Association (Bracelpa), from 1996 to 2004.

He earned a Bachelor’s degree in Business Administration from Fundação Getulio Vargas (FGV) in 1974 and attended seminars of the International Institute for Management Development (IMD) in Switzerland and in the United States (Harvard, Boston).